S&P/ASX 200 on track for seventh consecutive month of gains
Amazon on Thursday released first-quarter results that exceeded analysts’ expectations, with sales soaring 44% year-over-year to US$108.5 billion and profits more than tripling to US$8.1 billion. Brent crude oil price rose 1.3% to US$68.16 a barrel on Thursday.
S&P/ASX 200 (INDEXASX:XJO) dipped 0.60% to 7,039.5 points by 12.51 pm even as US markets rose overnight on strong corporate earnings data.
Locally, this is a second weekly decline a row, but the ASX 200 remains firmer for the month with a gain of 3.6%.
This would make it a seventh straight month of gains with the market rising about 20% in this time.
FTSE 100 closes on the front foot, with AstraZeneca the top riser
Footsie finished Friday ahead by around eight points, or 0.12%, at 6,969,
FTSE 100 closes around eight points higher
AstraZeneca top blue-chip riser
5.05pm: FTSE closes ahead
FTSE 100 closed on the front foot at the end of the trading week, with drugs giant and much-in-the-news COVID-19 vaccine producer AstraZeneca (LON:AZN) the top dog.
Footsie finished ahead by around eight points, or 0.12%, at 6,969, with the psychologically significant 7,000 level now coming back into view.
Over the week as a whole , the FTSE 100 added around 0.45%.
AstraZeneca shares closed up over 4% at 7,715p as traders welcomed an upbeat first quarterly results statement, which showed sales of US$7.3 billion, around 15% higher compared to the first quarter of 2020.
FTSE 100 closes on the front foot, with AstraZeneca the top riser
Footsie finished Friday ahead by around eight points, or 0.12%, at 6,969,
FTSE 100 closes around eight points higher
AstraZeneca top blue-chip riser
5.05pm: FTSE closes ahead
FTSE 100 closed on the front foot at the end of the trading week, with drugs giant and much-in-the-news COVID-19 vaccine producer AstraZeneca (LON:AZN) the top dog.
Footsie finished ahead by around eight points, or 0.12%, at 6,969, with the psychologically significant 7,000 level now coming back into view.
Over the week as a whole , the FTSE 100 added around 0.45%.
AstraZeneca shares closed up over 4% at 7,715p as traders welcomed an upbeat first quarterly results statement, which showed sales of US$7.3 billion, around 15% higher compared to the first quarter of 2020.
FTSE 100 closes on the front foot, with AstraZeneca the top riser
Footsie finished Friday ahead by around eight points, or 0.12%, at 6,969,
FTSE 100 closes around eight points higher
AstraZeneca top blue-chip riser
5.05pm: FTSE closes ahead
FTSE 100 closed on the front foot at the end of the trading week, with drugs giant and much-in-the-news COVID-19 vaccine producer AstraZeneca (LON:AZN) the top dog.
Footsie finished ahead by around eight points, or 0.12%, at 6,969, with the psychologically significant 7,000 level now coming back into view.
Over the week as a whole , the FTSE 100 added around 0.45%.
AstraZeneca shares closed up over 4% at 7,715p as traders welcomed an upbeat first quarterly results statement, which showed sales of US$7.3 billion, around 15% higher compared to the first quarter of 2020.
FTSE 100 closes on the front foot, with AstraZeneca the top riser
Footsie finished Friday ahead by around eight points, or 0.12%, at 6,969,
FTSE 100 closes around eight points higher
AstraZeneca top blue-chip riser
5.05pm: FTSE closes ahead
FTSE 100 closed on the front foot at the end of the trading week, with drugs giant and much-in-the-news COVID-19 vaccine producer AstraZeneca (LON:AZN) the top dog.
Footsie finished ahead by around eight points, or 0.12%, at 6,969, with the psychologically significant 7,000 level now coming back into view.
Over the week as a whole , the FTSE 100 added around 0.45%.
AstraZeneca shares closed up over 4% at 7,715p as traders welcomed an upbeat first quarterly results statement, which showed sales of US$7.3 billion, around 15% higher compared to the first quarter of 2020.